Overview
PFE market data
Price History
PFE price chart · 1M
- O
- 28.60
- H
- 28.69
- L
- 28.38
- C
- 28.45
- Vol
- 1,546,692.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $28.60
- Previous Close
- $28.81
- Day High
- $28.69
- Day Low
- $28.38
- 52 Week High
- $29.21
- 52 Week Low
- $23.21
- 7 Day Return
- +1.77%
- 30 Day Return
- +10.29%
- 90 Day Return
- +13.01%
- 1 Year Return
- +12.08%
- Daily Notional Volume
- $44M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 37.42 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $1.36 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.28 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 5.4% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 6.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $23.58 – $29.21 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $162.2B · P/B 1.64 · P/S 2.55.
Company News
10 captured
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool ·
Advanced Endometrial Cancer Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the Future of Advanced Endometrial Cancer Therapeutics Space | DelveInsightGlobenewswire Inc ·
Is BioNTech Stock a No-Brainer Buy on the Dip?The Motley Fool ·
Take Two Interactive, Nvidia, Cheniere Energy And A Health Care Stock: CNBC’s ‘Final Trades’Benzinga ·
CNBC Halftime Report Final Trades: Pfizer, Nvidia, Take-Two Interactive Software, Cheniere EnergyBenzinga ·